IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

NovaQuest Capital Management, L.L.C.

Q1 2019 Holdings

Filed 2019-05-08 | 4 holdings | $107.5K | 13F-HR | View on SEC ↗ · Holdings Table ↗

Sign in to see sub-manager breakdown

IssuerClassCUSIPValue ↓Shares% Portfolio
Myovant Sciences Ltd.COMG637AM102$82.9K3,474,64577.2%
Revance Therapeutics, Inc.(RVNCEUR)COM761330109$24.6K1,558,42622.8%